BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 9238169)

  • 1. Alterations of the putative tumor suppressor gene p16/MTS1 in human hematological malignancies.
    Duro D; Flexor MA; Bernard O; d'Agay MF; Berger R; Larsen CJ
    C R Acad Sci III; 1994 Oct; 317(10):913-9. PubMed ID: 7882134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.
    Herman JG; Merlo A; Mao L; Lapidus RG; Issa JP; Davidson NE; Sidransky D; Baylin SB
    Cancer Res; 1995 Oct; 55(20):4525-30. PubMed ID: 7553621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of the multi tumor suppressor gene-2 (MTS2, CDKN1, p15INK4B) in childhood acute lymphoblastic leukemia.
    Iravani M; Dhat R; Price CM
    Oncogene; 1997 Nov; 15(21):2609-14. PubMed ID: 9399648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of p16INK4A inactivation in non small-cell lung cancers.
    Gazzeri S; Gouyer V; Vour'ch C; Brambilla C; Brambilla E
    Oncogene; 1998 Jan; 16(4):497-504. PubMed ID: 9484839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FISH analysis of translocations involving the short arm of chromosome 9 in lymphoid malignancies.
    Leblanc T; Derré J; Flexor M; Le Coniat M; Leroux D; Rimokh R; Larsen CJ; Berger R
    Genes Chromosomes Cancer; 1997 Aug; 19(4):273-7. PubMed ID: 9258663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tribulations of the p16/MTS1/CDKN2 tumor gene suppressor: a continuing saga].
    Larsen CJ
    Bull Cancer; 1997 Apr; 84(4):427-30. PubMed ID: 9238169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibitors of cyclins/CDK of the 9p21 chromosomal region and malignant hemopathies].
    Quesnel B
    Bull Cancer; 1998 Sep; 85(9):747-54. PubMed ID: 9817058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alternative protein p19ARF: a genuine tumor suppressor gene].
    Larsen CJ
    Bull Cancer; 1998 Apr; 85(4):304-6. PubMed ID: 9752293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecullar structure and function of the p16/INK4a/CDKN2/MTS1 and the INK4 family, and their association with carcinogenesis].
    Okamoto A; Tanaka T
    Nihon Rinsho; 1996 Apr; 54(4):1037-42. PubMed ID: 8920670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p16ink4a gene and hematological malignancies.
    Quesnel B; Preudhomme C; Fenaux P
    Leuk Lymphoma; 1996 Jun; 22(1-2):11-24. PubMed ID: 8724524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of the dual coding capacity of the p16INK4a/MTS1/CDKN2 locus to human malignancies.
    Larsen CJ
    Prog Cell Cycle Res; 1997; 3():109-24. PubMed ID: 9552410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Discovery of a new gene frequently inactivated in human cancers: protein p16, a cell cycle regulator].
    Bressac-de Paillerets B
    Bull Cancer; 1994 Oct; 81(10):853-6. PubMed ID: 7734767
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.